These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
612 related items for PubMed ID: 10537067
1. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons. Takahashi M, Yasutake K, Tomizawa K. J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067 [Abstract] [Full Text] [Related]
2. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. Lucas JJ, Hernández F, Gómez-Ramos P, Morán MA, Hen R, Avila J. EMBO J; 2001 Jan 15; 20(1-2):27-39. PubMed ID: 11226152 [Abstract] [Full Text] [Related]
6. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A. Oncogene; 2000 Jan 27; 19(4):537-45. PubMed ID: 10698523 [Abstract] [Full Text] [Related]
8. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, Ishiguro K, Yamaguchi H. Neurosci Res; 1998 Aug 27; 31(4):317-23. PubMed ID: 9809590 [Abstract] [Full Text] [Related]
12. Coexpression of GSK-3beta corrects phenotypic aberrations of dorsal root ganglion cells, cultured from adult transgenic mice overexpressing human protein tau. Nuydens R, Van Den Kieboom G, Nolten C, Verhulst C, Van Osta P, Spittaels K, Van den Haute C, De Feyter E, Geerts H, Van Leuven F. Neurobiol Dis; 2002 Feb 27; 9(1):38-48. PubMed ID: 11848683 [Abstract] [Full Text] [Related]
13. Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassembly. Elyaman W, Yardin C, Hugon J. J Neurochem; 2002 May 27; 81(4):870-80. PubMed ID: 12065646 [Abstract] [Full Text] [Related]
14. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells. Ishii T, Furuoka H, Muroi Y, Nishimura M. J Biol Chem; 2003 Jul 18; 278(29):26970-5. PubMed ID: 12714590 [Abstract] [Full Text] [Related]
15. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. Imahori K, Uchida T. J Biochem; 1997 Feb 18; 121(2):179-88. PubMed ID: 9089387 [Abstract] [Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons. Zhang Z, Zhao R, Qi J, Wen S, Tang Y, Wang D. J Neurosci Res; 2011 Mar 18; 89(3):437-47. PubMed ID: 21259330 [Abstract] [Full Text] [Related]
17. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation. Selenica ML, Jensen HS, Larsen AK, Pedersen ML, Helboe L, Leist M, Lotharius J. Br J Pharmacol; 2007 Nov 18; 152(6):959-79. PubMed ID: 17906685 [Abstract] [Full Text] [Related]